Profile data is unavailable for this security.
About the company
C-Rad AB is a Sweden-based holding company active in the medical equipment industry. It offers products and solutions to the radiation therapy market. C-Rad AB is the parent company within the C-Rad group (the Group). The Group provides such products, as Sentinel, a surface contour laser scanning system for patient positioning, monitoring and gating applications; Catalyst, a surface scanning system, which allows the identification and tracking of markers, and GEMini, a system based on a gaseous detector using metal converters interleaved with Gas Electron Multipliers (GEMs), as well as other products. The Company operates through several subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB, C-RAD Innovation AB and Cyrpa International Sprl. The Company’s largest shareholder is Inter Life Science AB.
- Revenue in SEK (TTM)458.22m
- Net income in SEK48.23m
- Incorporated2004
- Employees89.00
- LocationC Rad ABSjukhusvagen 12KUPPSALA 753 09SwedenSWE
- Phone+46 18666930
- Fax+46 18666930
- Websitehttps://c-rad.se/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omda AS | 404.31m | 87.68m | 648.08m | 295.00 | 7.36 | 11.48 | 4.38 | 1.60 | 4.35 | 4.35 | 20.60 | 2.79 | 0.5886 | 238.36 | 10.38 | 1,434,162.00 | 13.80 | -4.92 | 18.03 | -6.37 | 92.89 | 90.22 | 23.45 | -9.83 | 1.14 | 2.56 | 0.8946 | -- | 12.30 | 19.83 | 179.30 | -- | -3.93 | -- |
| Senzime AB (publ) | 47.04m | -130.32m | 653.68m | 52.00 | -- | 2.43 | -- | 13.90 | -1.16 | -1.16 | 0.4152 | 2.67 | 0.1279 | 1.44 | 4.39 | -- | -35.42 | -35.69 | -37.96 | -38.00 | 29.89 | -20.59 | -277.04 | -558.68 | 3.61 | -- | 0.07 | -- | 154.77 | 61.90 | -1.09 | -- | -3.69 | -- |
| Gentian Diagnostics ASA | 141.73m | -1.95m | 684.29m | 58.00 | -- | 4.49 | 97.37 | 4.83 | -0.1369 | -0.1369 | 9.43 | 10.20 | 0.7756 | 1.71 | 6.79 | 2,522,379.00 | -1.07 | -10.76 | -1.21 | -11.86 | 51.06 | 41.46 | -1.37 | -26.99 | 4.83 | -- | 0.047 | -- | 32.98 | 27.63 | 54.92 | -- | -4.92 | -- |
| OssDsign AB | 123.46m | -113.80m | 706.07m | 27.00 | -- | 3.14 | -- | 5.72 | -1.40 | -1.40 | 1.43 | 2.30 | 0.4311 | 2.50 | 6.80 | 2,572,083.00 | -39.74 | -37.92 | -43.39 | -43.56 | 83.94 | 68.10 | -92.18 | -203.06 | 5.92 | -21.65 | 0.0114 | -- | 96.84 | 53.26 | -31.30 | -- | -56.16 | -- |
| Mentice AB | 280.75m | -10.20m | 728.71m | 134.00 | -- | 4.78 | 44.07 | 2.60 | -0.3998 | -0.3998 | 10.95 | 5.97 | 0.9046 | 3.05 | 3.28 | 2,301,221.00 | -3.29 | -7.69 | -6.32 | -13.07 | 85.36 | 83.67 | -3.63 | -10.00 | 1.00 | -- | 0.0382 | -- | 25.54 | 11.74 | 90.81 | -- | -10.83 | -- |
| Paxman AB (publ) | 238.86m | 28.64m | 1.13bn | 102.00 | 39.38 | 7.72 | 23.98 | 4.71 | 1.50 | 1.50 | 12.54 | 7.67 | 1.31 | 2.74 | 6.56 | 2,624,791.00 | 15.66 | -5.08 | 20.74 | -7.76 | 70.27 | 69.38 | 11.99 | -5.07 | 1.98 | 12.73 | 0.0838 | -- | 43.99 | 29.35 | 180.69 | -- | 6.26 | -- |
| Optomed Oyj | 166.84m | -55.03m | 1.15bn | 110.00 | -- | 3.70 | -- | 6.89 | -0.2761 | -0.2761 | 0.8501 | 1.40 | 0.4762 | 1.69 | 4.10 | 129,035.10 | -15.71 | -12.95 | -19.11 | -15.90 | 67.77 | 65.69 | -32.98 | -27.84 | 2.67 | -- | 0.1424 | -- | 3.00 | 3.47 | 18.84 | -- | 7.26 | -- |
| C Rad AB | 458.22m | 48.23m | 1.23bn | 89.00 | 26.18 | 4.34 | 21.41 | 2.69 | 1.43 | 1.43 | 13.57 | 8.61 | 1.20 | 4.90 | 3.05 | 5,266,839.00 | 12.69 | 5.09 | 17.96 | 7.02 | 45.14 | 43.12 | 10.61 | 4.86 | 2.43 | -- | 0.0058 | 0.00 | 40.92 | 17.44 | 375.05 | 10.89 | 33.69 | -- |
| BioPorto A/S | 51.44m | -76.05m | 1.25bn | 33.00 | -- | 7.87 | -- | 24.39 | -0.1397 | -0.1397 | 0.0941 | 0.244 | 0.2777 | 3.23 | 9.02 | 1,091,290.00 | -41.06 | -71.10 | -51.28 | -96.55 | 71.13 | 63.38 | -147.84 | -239.22 | 5.16 | -- | 0.0517 | -- | 6.87 | 3.54 | 25.81 | -- | -51.56 | -- |
| ADDvise Group AB (publ) | 1.54bn | 137.40m | 1.46bn | 637.00 | 21.69 | 3.80 | 6.11 | 0.944 | 0.7191 | 0.7191 | 8.07 | 4.10 | 0.5142 | 7.24 | 5.04 | 2,474,039.00 | 4.58 | 3.72 | 5.63 | 4.77 | 44.82 | 48.95 | 8.91 | 5.89 | 1.36 | 3.24 | 0.6913 | 0.9405 | 44.30 | 38.62 | 27.62 | -- | 30.35 | -- |
| Genovis AB | 127.02m | 17.25m | 1.51bn | 37.00 | 87.29 | 7.25 | 51.80 | 11.85 | 0.2635 | 0.2635 | 1.94 | 3.17 | 0.4938 | -- | -- | 3,432,973.00 | 6.71 | 18.56 | 7.21 | 21.45 | 64.41 | 65.51 | 13.58 | 23.88 | -- | 697.00 | 0.2718 | 0.00 | 54.54 | 35.56 | 449.56 | -- | 47.59 | -- |
| Nordhealth As | 468.27m | -105.80m | 1.62bn | 355.00 | -- | 3.19 | 98.02 | 3.46 | -1.40 | -1.40 | 6.17 | 11.59 | 0.4329 | -- | 6.73 | 1,223,696.00 | -9.78 | -- | -11.11 | -- | 85.82 | -- | -22.59 | -- | -- | -- | 0.00 | -- | 18.60 | -- | 21.96 | -- | -- | -- |
Data as of Sep 20 2024. Currency figures normalised to C Rad AB's reporting currency: Swedish Krona SEK
18.56%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Eiffel Investment Group SASas of 30 Jun 2023 | 1.09m | 3.33% |
| Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 31 Aug 2023 | 905.64k | 2.75% |
| Deka Investment GmbHas of 30 Apr 2023 | 828.50k | 2.52% |
| Cliens Kapitalf�rvaltning ABas of 31 Dec 2023 | 783.83k | 2.38% |
| Handelsbanken Fonder ABas of 31 Aug 2024 | 707.59k | 2.15% |
| Aktia Bank Plc (Investment Management)as of 30 Aug 2024 | 500.00k | 1.52% |
| Aktia Fondbolag Abas of 28 Jun 2023 | 500.00k | 1.52% |
| Schroder Investment Management Ltd.as of 31 Dec 2023 | 335.00k | 1.02% |
| Mandarine Gestion SAas of 31 Mar 2023 | 294.99k | 0.90% |
| SEB Investment Management ABas of 30 Aug 2024 | 158.06k | 0.48% |
More ▼
Data from 30 Sep 2023 - 30 Aug 2024Source: FactSet Research Systems Inc.
